Preclinical testing as well as potency evaluation of biological products is dependent on the establishment of the accepted international in vitro and in vivo models. The platform functions as a national preclinical testing platform for qualitative and quantitative preclinical studies for research institutions and companies by:

• Performing  pharmacokinetic, selected toxicology and safety pharmacology studies for new compounds and/or formulations.
• Performing potency & safety batch release assays of biologically-based products.
• Developing, establishing and maintaining models as it relates to infectious diseases, chronic conditions, neurobiology and treatment of a variety of disorders.
• Establishing the infrastructure and skills set required for performing the various in vitro and in vivo studies during the preclinical phase of drug development.
• Creating an enabling environment to attract both local and international customers to use of the facility.
• Creating an infrastructure that could enable South Africa to play a significant role in the production of pharmaceutical drugs and phyto-medicines.